Peptonic Medical
0.002
SEK
0 %
Less than 1K followers
PMED
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.
Read moreMarket cap
16.81M SEK
Turnover
73.23K SEK
Revenue
26.89M
EBIT %
-218.11 %
P/E
-
Dividend yield-%
-
Financial calendar
26/6
2025
General meeting '25
13/8
2025
Interim report Q2'25
6/11
2025
Interim report Q3'25
All
Press releases
ShowingAll content types
PEPTONIC Medical AB: Peptonic Medical: Request for extension of company reconstruction and update on the reconstruction process
PEPTONIC Medical AB: RÄTTELSE: Peptonic Medicals årsredovisning för 2024 publicerad
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools